HK1031322A1 - Treatment of stress and preconditioning against stress - Google Patents

Treatment of stress and preconditioning against stress

Info

Publication number
HK1031322A1
HK1031322A1 HK00108537A HK00108537A HK1031322A1 HK 1031322 A1 HK1031322 A1 HK 1031322A1 HK 00108537 A HK00108537 A HK 00108537A HK 00108537 A HK00108537 A HK 00108537A HK 1031322 A1 HK1031322 A1 HK 1031322A1
Authority
HK
Hong Kong
Prior art keywords
radiation
ozone
stress
mild heating
oxygen gas
Prior art date
Application number
HK00108537A
Other languages
English (en)
Inventor
Pavel Hamet
Johanne Tremblay
Original Assignee
Vasogen Ireland Ltd
Ct De Rech Du Ct Hospitalier D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA 2218625 external-priority patent/CA2218625A1/en
Priority claimed from CA 2230836 external-priority patent/CA2230836A1/en
Application filed by Vasogen Ireland Ltd, Ct De Rech Du Ct Hospitalier D filed Critical Vasogen Ireland Ltd
Publication of HK1031322A1 publication Critical patent/HK1031322A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/32—Oxygenators without membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/369—Temperature treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/05—General characteristics of the apparatus combined with other kinds of therapy
    • A61M2205/051—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy
    • A61M2205/053—General characteristics of the apparatus combined with other kinds of therapy with radiation therapy ultraviolet

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Neurology (AREA)
  • Inorganic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Magnetic Heads (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Dental Preparations (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK00108537A 1997-09-12 2000-12-28 Treatment of stress and preconditioning against stress HK1031322A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5878297P 1997-09-12 1997-09-12
US5917297P 1997-09-17 1997-09-17
CA 2218625 CA2218625A1 (en) 1997-09-12 1997-10-20 Stress treatment and preconditioning against stress
CA 2230836 CA2230836A1 (en) 1998-02-27 1998-02-27 Inducing resistance to ischemic stresses
PCT/CA1998/000869 WO1999013890A1 (en) 1997-09-12 1998-09-11 Treatment of stress and preconditioning against stress

Publications (1)

Publication Number Publication Date
HK1031322A1 true HK1031322A1 (en) 2001-06-15

Family

ID=27427399

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00108537A HK1031322A1 (en) 1997-09-12 2000-12-28 Treatment of stress and preconditioning against stress

Country Status (13)

Country Link
EP (1) EP1011696B1 (de)
JP (1) JP4141636B2 (de)
AT (1) ATE253922T1 (de)
AU (1) AU741181B2 (de)
DE (1) DE69819749T2 (de)
DK (1) DK1011696T3 (de)
EA (1) EA003232B1 (de)
ES (1) ES2210814T3 (de)
HK (1) HK1031322A1 (de)
IL (3) IL135018A0 (de)
NZ (1) NZ503770A (de)
PT (1) PT1011696E (de)
WO (1) WO1999013890A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ512849A (en) * 1999-01-12 2003-02-28 Ct De Rech Du Ct Hospitalier D Pre-conditioning against cell death
US7045124B1 (en) 1999-01-12 2006-05-16 Vasogen Irelend Limited Pre-conditioning against cell death
CA2271190A1 (en) * 1999-05-06 2000-11-06 Vasogen Ireland Limited Improved method for treating mammals with modified mammalian blood
PT1214037E (pt) * 1999-09-16 2004-08-31 Vasogen Ireland Ltd Aparelho e processo para o condicionamento de sangue de mamiferos
US7125897B1 (en) 1999-09-24 2006-10-24 Vasogen Ireland Limited Combined therapies for atherosclerosis treatment
CA2296997A1 (en) * 2000-01-18 2001-07-18 Vasogen Ireland Limited Treatment of congestive heart failure
EP1427394B1 (de) * 2001-09-18 2007-03-14 Vasogen Ireland Limited Verwendung von synthetischen oder natürlichen apoptose-vortäuschenden eiinheiten zur beschleunigten erholung von verletzungen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591457A (en) * 1992-02-07 1997-01-07 Vasogen Inc Method of inhibiting the aggregation of blood platelets and stimulating the immune systems of a human
US5980954A (en) * 1992-02-07 1999-11-09 Vasogen Ireland Limited Treatment of autoimmune diseases
DE69334101T2 (de) * 1992-02-07 2007-10-04 Vasogen Ireland Ltd., Shannon Verwendung von Blut mit erhöhter Stickoxidkonzentration zur Herstellung eines Medikaments
JPH08652A (ja) * 1994-06-24 1996-01-09 Oskar:Kk 男性機能回復補助器具
JPH10506636A (ja) * 1995-05-05 1998-06-30 バソゲン・インコーポレーテッド 内皮ライニング効果及び血管痙攣性疾患の治療
JPH09227394A (ja) * 1995-12-22 1997-09-02 Taisho Pharmaceut Co Ltd 経口投与用組成物

Also Published As

Publication number Publication date
NZ503770A (en) 2002-10-25
EP1011696A1 (de) 2000-06-28
EA200000312A1 (ru) 2001-04-23
DK1011696T3 (da) 2004-03-15
IL135018A0 (en) 2001-05-20
JP4141636B2 (ja) 2008-08-27
EA003232B1 (ru) 2003-02-27
WO1999013890A1 (en) 1999-03-25
ATE253922T1 (de) 2003-11-15
AU741181B2 (en) 2001-11-22
PT1011696E (pt) 2004-03-31
JP2001516723A (ja) 2001-10-02
EP1011696B1 (de) 2003-11-12
AU9148098A (en) 1999-04-05
IL135018A (en) 2006-06-11
DE69819749T2 (de) 2004-09-30
IL135014A0 (en) 2001-05-20
DE69819749D1 (de) 2003-12-18
ES2210814T3 (es) 2004-07-01

Similar Documents

Publication Publication Date Title
BG101284A (en) Compounds and methods for cancer treatment
GB2290479B (en) Medical appliance for intermittent compression treatment
BR9405763A (pt) Processo para tratar fluido corpóreo processo para tratar produto de sangue e processo para fornecer produtos de sangue a paciente
MX9300607A (es) Aparato y metodo para tratamiento intersticial.
KR900700398A (ko) 유기 화합물의 처리 방법
BR9916879A (pt) Composição e método para tratamento do câncer utilizando óleos essenciais vegetais naturais
ES2196530T3 (es) Compuestos de ruptura para inactivar patogenos.
HK1031322A1 (en) Treatment of stress and preconditioning against stress
ES2157833A1 (es) Procedimiento para el tratamiento de suelas de zapatos mediante radiacion ultravioleta combinada con ozono.
ES2164914T3 (es) Medicamentos de inmunoterapia que contienen anticuerpos que detectan especificamente el antigeno mhcii del paciente a tratar.
AU2566295A (en) Photodynamic conjugates with biocidal properties
EA199700241A1 (ru) Новые, определенные по составу смеси ферментов для выделения клеток и лечения ран
EP0728219A4 (de) Nassbehandlung von leder und pelzen
WO1998010774A3 (en) Use of ozone for treating diseases of body cavity tissues, and apparatus therefore
MY120530A (en) Combination preparation for use in dementia
MX9307667A (es) Metodo de tratamiento termico rapido para fibra de polibenzazol.
ES2046944B1 (es) Procedimiento para la destruccion de microorganismos y enzimas mediante la aplicacion combinada de calor y ultrasonidos bajo presion: proceso mts (mano-termo-sonicacion).
SG49210A1 (en) Composition for use in the treatment f tumours and the immunization of organisms against tumours
PL336163A1 (en) Application of oligomeric cartilage intercellular substance protein in treating rheumatologic arthritis
AU1275400A (en) Method and apparatus for treating contaminated waste
EP0569531A4 (de) Stabilisierte antikörperfragmente.
UA32241A (uk) Спосіб лікування запалювальних процесів у експериментальних тварин
EP0321094A3 (de) Behandlung von Faktor-VIII-Inhibitoren
UA7955A (uk) Спосіб лікування туберкульозу легенів
Li et al. Failure analysis of bi-metal band saw blades

Legal Events

Date Code Title Description
PF Patent in force